A Study on the Development of Biotechnology Industry in Singapore PDF Download

Author: Joon Khoi Lam
Publisher:
ISBN:
Category :
Languages : en
Pages : 180

View

Book Description

Author: Emma Armitage
Publisher:
ISBN:
Category : Biotechnology industries
Languages : en
Pages : 188

View

Book Description
In 2000, Singapore's government launched a strategy to establish the biotechnology industry as one of the pillars of its future economic growth. This targeted 'causative' process involved support policies, the creation and strengthening of research bodies, construction of a purpose-built bio-hub, attraction of foreign drug companies, and investment in local start-ups. These organisations, support factors, and the networks between them constitute Singapore's national innovation system as it relates to biotech. Fourteen years on, Singapore's causative approach has resulted in job creation and increased per capita income. It has also seen many of biotechnology's top multinational corporations base a section of their operations within the country. However, the country's innovation system has yet to produce a community of Singapore-started small and medium sized dedicated biotechnology firms, referred to here as SDBFs. Small and medium sized firms are key drivers of innovation in the biotechnology sector and their presence is necessary to create a sustainable cluster. There is considerable interest from academia and industry in understanding and learning from the development of Singapore's local firms under its national innovation system. Hence, the purpose of this thesis is to study how Singapore's national innovation system has affected its biotechnology sector, with particular focus on its effect on SDBFs. This thesis used mixed methods to investigate the research question. The quantitative approach involved the construction of a database of Singapore-started biotechnology firms and their characteristics. The qualitative method utilised semi-structured interviews with 16 professionals in Singapore's biotechnology sector. The findings pointed to several key conclusions. Firstly, participants felt that increases in the availability of commercialisable patents, risk-comfortable venture capitalists, and entrepreneurial individuals are necessary factors to promote the emergence and success of start-up firms. Findings also showed that the majority of SDBFs studied are located outside of purpose-built hubs, which participants suggested might influence their business model. In addition, SDBFs appeared to be moving into the relatively 'lower risk' sub-sector of medical devices. Overall, a critical mass of firms, human capital, and support factors emerged as a state that Singapore must reach for the industry to thrive. This research builds on the body of work concerning the national innovation system framework and Singapore's biotechnology industry. It acts as a snapshot in time of SDBFs and the perspectives of a sample of individuals in the biotechnology industry. The data gathered here outlines the effect Singapore's national innovation system has had on the industry and emphasises the importance of the critical mass concept. This can be used to inform future policies and as an indicator of the characteristics of the SDBF level of the industry.

Author: Joseph Wong
Publisher: Cornell University Press
ISBN: 0801463378
Category : Political Science
Languages : en
Pages : 217

View

Book Description
After World War II, several late-developing countries registered astonishingly high growth rates under strong state direction, making use of smart investment strategies, turnkey factories, and reverse-engineering, and taking advantage of the postwar global economic boom. Among these economic miracles were postwar Japan and, in the 1960s and 1970s, the so-called Asian Tigers—Singapore, South Korea, and Taiwan—whose experiences epitomized the analytic category of the "developmental state." In Betting on Biotech, Joseph Wong examines the emerging biotechnology sector in each of these three industrial dynamos. They have invested billions of dollars in biotech industries since the 1990s, but commercial blockbusters and commensurate profits have not followed. Industrial upgrading at the cutting edge of technological innovation is vastly different from the dynamics of earlier practices in established industries. The profound uncertainties of life-science-based industries such as biotech have forced these nations to confront a new logic of industry development, one in which past strategies of picking and making winners have given way to a new strategy of throwing resources at what remain very long shots. Betting on Biotech illuminates a new political economy of industrial technology innovation in places where one would reasonably expect tremendous potential—yet where billion-dollar bets in biotech continue to teeter on the brink of spectacular failure.

Author: Kenny Hwee Seong Ching
Publisher:
ISBN:
Category :
Languages : en
Pages : 110

View

Book Description
Clusters comprise of a particular set of ingredients, which includes researchers, entrepreneurs, venture capitalists, well-trained and educated workers, and specialized professional services. The importance of each ingredient is undeniable, yet the proximity to research centers and institutions is perhaps the most critical element of success for technology clusters. This thesis focuses on the Massachusetts Institute of Technology (MIT), and examines its role in the development of the biomedical industry cluster in Cambridge, Massachusetts. However, while the important role that academic institutions play in the process of transforming science to marketable technology is acknowledged, the question of who are the actual researchers most intimately involved in this process remains unanswered. Drawing on quantitative data, we show that the majority of commercially related research work is performed by a small fraction of the researchers, and this group is heterogeneous in characteristics. Moreover, through a novel way of examining publication data, we also show that the commercial productivity of each researcher is positively related to the researcher's relative level of applied science research. Over the past two years, Singapore has been among the most aggressive of the East Asian countries in pursuing the development of its biotechnology industry. By benchmarking Singapore against MIT, we recommend that Singapore raise its level of applied science research, to improve the integration of academic research into the marketplace.

Author: Bryan Bergeron
Publisher: John Wiley & Sons
ISBN: 0471647578
Category : Business & Economics
Languages : en
Pages : 384

View

Book Description
"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures. An in-depth examination of the growth and financing of the biotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing. Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.

Author:
Publisher:
ISBN:
Category : Biotechnology
Languages : en
Pages : 32

View

Book Description

Author: Sachin Chaturvedi
Publisher: Academic Foundation
ISBN: 9788171883462
Category : Political Science
Languages : en
Pages : 334

View

Book Description
Biotechnology Is At The Heart Of Technology Revolution In Asia Today With Immense Potential In The Pharmaceutical And Agriculture Sectors. This Study Covers Economic And Policy Issues And The Experiences In Biotechnology In Japan, India, Malaysia, The Phillipines, Korea, Bangladesh, Thailand, China And Singapore And Also The International Cooperative Strategies Of Asean And In Europe. This Book Is A Valuable Resource For Governments, Multilateral Institutions, Academics And Practitioners In The Field Of Economic Development And Technology Policy Management.

Author: Shawn Hsia
Publisher:
ISBN:
Category : Biotechnology industries
Languages : en
Pages : 138

View

Book Description

Author: National Research Council
Publisher: National Academies Press
ISBN: 0309316553
Category : Science
Languages : en
Pages : 158

View

Book Description
The tremendous progress in biology over the last half century - from Watson and Crick's elucidation of the structure of DNA to today's astonishing, rapid progress in the field of synthetic biology - has positioned us for significant innovation in chemical production. New bio-based chemicals, improved public health through improved drugs and diagnostics, and biofuels that reduce our dependency on oil are all results of research and innovation in the biological sciences. In the past decade, we have witnessed major advances made possible by biotechnology in areas such as rapid, low-cost DNA sequencing, metabolic engineering, and high-throughput screening. The manufacturing of chemicals using biological synthesis and engineering could expand even faster. A proactive strategy - implemented through the development of a technical roadmap similar to those that enabled sustained growth in the semiconductor industry and our explorations of space - is needed if we are to realize the widespread benefits of accelerating the industrialization of biology. Industrialization of Biology presents such a roadmap to achieve key technical milestones for chemical manufacturing through biological routes. This report examines the technical, economic, and societal factors that limit the adoption of bioprocessing in the chemical industry today and which, if surmounted, would markedly accelerate the advanced manufacturing of chemicals via industrial biotechnology. Working at the interface of synthetic chemistry, metabolic engineering, molecular biology, and synthetic biology, Industrialization of Biology identifies key technical goals for next-generation chemical manufacturing, then identifies the gaps in knowledge, tools, techniques, and systems required to meet those goals, and targets and timelines for achieving them. This report also considers the skills necessary to accomplish the roadmap goals, and what training opportunities are required to produce the cadre of skilled scientists and engineers needed.

Author: Chang Chieh Hang
Publisher: World Scientific
ISBN: 9814641286
Category : Science
Languages : en
Pages : 325

View

Book Description
Ever since Singapore became independent in 1965, its leaders have invested tremendous efforts and resources to develop its economy in order to create jobs for its people and to support national development. This book describes the challenging journey of Singapore in developing a knowledge-based economy driven by research and innovation and the roles played by research institutes, universities, research manpower and appropriate collaboration between research institutes and industry.The book traces the foundations of Singapore's research story from the time of its independence in 1965 to the present day. Through interviews with the key players and research into the records, the establishment of the key institutes and the roles of a global cast of researchers, scientists and engineers in setting up the R&D infrastructure are outlined. The impact of the concerted efforts to build up a credible and world-class research capability in Singapore over the last 25 years is discussed, as are the tremendous challenges faced by the key players in the drive to develop a knowledge-based economy and the ultimate goal of an innovation-driven economy.